Calcitriol

Title	Average Rating
Weekly high-dose calcitriol and docetaxel in metastatic androgen-independent prostate cancer.	80.00%
Multiple cycles of intermittent chemotherapy in metastatic androgen-independent prostate cancer.	70.00%
Double-blinded randomized study of high-dose calcitriol plus docetaxel compared with placebo plus docetaxel in androgen-indep..	70.00%
Phase II study of calcitriol-enhanced docetaxel in patients with previously untreated metastatic or locally advanced pancreatic	40.00%

Languages